230 related articles for article (PubMed ID: 15839224)
1. [High-frequency oscillatory lung ventilation in complex therapy for congenital pneumonia and hyaline membrane disease in newborns].
Antonov AG; Ionov OV; Burkova AS
Anesteziol Reanimatol; 2005; (1):41-4. PubMed ID: 15839224
[TBL] [Abstract][Full Text] [Related]
2. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL
Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856
[TBL] [Abstract][Full Text] [Related]
3. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
[TBL] [Abstract][Full Text] [Related]
4. [High frequency ventilation by oscillation].
Salle BL; Claris O; Putet G
Pediatrie; 1993; 48(12):861-3. PubMed ID: 8047396
[TBL] [Abstract][Full Text] [Related]
5. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
Gonda TA; Hutchins GM
Am J Perinatol; 1998; 15(9):539-44. PubMed ID: 9890252
[TBL] [Abstract][Full Text] [Related]
6. [High frequency ventilation by oscillation in the treatment of the hyaline membrane disease in severe form].
Cortambert F; Putet G; Salle B; Deiber M
Arch Fr Pediatr; 1988 Apr; 45(4):243-7. PubMed ID: 3136752
[TBL] [Abstract][Full Text] [Related]
7. Neuromotor outcome at 2 years of very preterm infants who were treated with high-frequency oscillatory ventilation or conventional ventilation for neonatal respiratory distress syndrome.
Truffert P; Paris-Llado J; Escande B; Magny JF; Cambonie G; Saliba E; Thiriez G; Zupan-Simunek V; Blanc T; Rozé JC; Bréart G; Moriette G
Pediatrics; 2007 Apr; 119(4):e860-5. PubMed ID: 17339385
[TBL] [Abstract][Full Text] [Related]
8. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
Mandy GT; Moïse AA; Smith EO; Hansen TN
J Perinatol; 1998; 18(6 Pt 1):444-8. PubMed ID: 9848758
[TBL] [Abstract][Full Text] [Related]
9. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
[TBL] [Abstract][Full Text] [Related]
10. The late administration of surfactant.
Ballot DE; Rothberg AD; Davies VA
S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
[TBL] [Abstract][Full Text] [Related]
11. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
Helbich TH; Popow C; Dobner M; Wunderbaldinger P; Zekert M; Herold CJ
Eur J Radiol; 1998 Oct; 28(3):243-9. PubMed ID: 9881260
[TBL] [Abstract][Full Text] [Related]
12. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
Teksam O; Kale G
Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
[TBL] [Abstract][Full Text] [Related]
13. Hyaline membrane disease treated with bovine surfactant.
Smyth JA; Metcalfe IL; Duffty P; Possmayer F; Bryan MH; Enhorning G
Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
Sánchez-Mendiola M; Martínez-Natera OC; Herrera-Maldonado N; Ortega-Arroyo J
Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120
[TBL] [Abstract][Full Text] [Related]
15. Surfactant replacement therapy in newborns with hyaline membrane disease.
Grobman DW; Foley MM
Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
[TBL] [Abstract][Full Text] [Related]
16. Rescue ventilation with high frequency oscillation in premature baboons with hyaline membrane disease.
deLemos RA; Coalson JJ; deLemos JA; King RJ; Clark RH; Gerstmann DR
Pediatr Pulmonol; 1992 Jan; 12(1):29-36. PubMed ID: 1579373
[TBL] [Abstract][Full Text] [Related]
17. Artificial ventilation in hyaline membrane disease: the use of positive end-expiratory pressure and continuous positive airway pressure.
Cumarasamy N; Nüssli R; Vischer D; Dangel PH; Duc GV
Pediatrics; 1973 Apr; 51(4):629-40. PubMed ID: 4572543
[No Abstract] [Full Text] [Related]
18. Artificial ventilation with continuous positive airway pressure in the management of ventilatory insufficiency of the newborn.
Ganendran A; Kam CA; Wong CH
Singapore Med J; 1974 Dec; 15(4):261-7. PubMed ID: 4617305
[No Abstract] [Full Text] [Related]
19. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
Jin HZ; Chen C; Jin QL; Shao XM
Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
[TBL] [Abstract][Full Text] [Related]
20. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
